by rss feed | Dec 10, 2023 | Casgevy, Lyfgenia, News Feeds, Paolo Macchiarini, Sickle Cell Disease, weekly reads
The big news broke Friday that the FDA approved two new gene therapies for sickle cell disease. While the approvals were expected and the actual use of these treatments will be complex on several levels, this is a historic development. 2 FDA-approved gene therapies...
